Are Regulations Safe? Reflections From Developing a Digital Cancer Decision-Support Tool
- PMID: 33797951
- PMCID: PMC8140795
- DOI: 10.1200/CCI.20.00148
Are Regulations Safe? Reflections From Developing a Digital Cancer Decision-Support Tool
Abstract
Purpose: Informatics solutions to early diagnosis of cancer in primary care are increasingly prevalent, but it is not clear whether existing and planned standards and regulations sufficiently address patients' safety nor whether these standards are fit for purpose. We use a patient safety perspective to reflect on the development of a computerized cancer risk assessment tool embedded within a UK primary care electronic health record system.
Methods: We developed a computerized version of the CAncer Prevention in ExetER studies risk assessment tool, in compliance with the European Union's Medical Device Regulations. The process of building this tool afforded an opportunity to reflect on clinical concerns and whether current regulations for medical devices are fit for purpose. We identified concerns for patient safety and developed nine practical recommendations to mitigate these concerns.
Results: We noted that medical device regulations (1) were initially created for hardware devices rather than software, (2) offer one-shot approval rather than supporting iterative innovation and learning, (3) are biased toward loss-transfer approaches that attempt to manage the fallout of harm instead of mitigating hazards becoming harmful, and (4) are biased toward known hazards, despite unknown hazards being an expected consequence of health care as a complex adaptive system. Our nine recommendations focus on embedding less-reductionist and stronger system perspectives into regulations and standards.
Conclusion: Our intention is to share our experience to support research-led collaborative development of health informatics solutions in cancer. We argue that regulations in the European Union do not sufficiently address the complexity of healthcare information systems with consequences for patient safety. Future standards and regulations should continue to follow a system-based approach to risk, safety, and accident avoidance.
Figures


Similar articles
-
Software-Related Recalls of Health Information Technology and Other Medical Devices: Implications for FDA Regulation of Digital Health.Milbank Q. 2017 Sep;95(3):535-553. doi: 10.1111/1468-0009.12278. Milbank Q. 2017. PMID: 28895231 Free PMC article.
-
Health Informatics in Developing Countries: A Review of Unintended Consequences of IT Implementations, as They Affect Patient Safety and Recommendations on How to Address Them.Yearb Med Inform. 2016 Nov 10;(1):1-2. doi: 10.15265/IY-2016-028. Yearb Med Inform. 2016. PMID: 27830233 Free PMC article.
-
A comparative review of patient safety initiatives for national health information technology.Int J Med Inform. 2013 May;82(5):e139-48. doi: 10.1016/j.ijmedinf.2012.11.014. Epub 2012 Dec 21. Int J Med Inform. 2013. PMID: 23266061
-
Development and Regulation of Connected Combined Products: Reflections From the Medtech & Pharma Platform Association.Clin Ther. 2022 May;44(5):768-782. doi: 10.1016/j.clinthera.2022.03.009. Epub 2022 Apr 4. Clin Ther. 2022. PMID: 35393132 Review.
-
Measuring and improving patient safety through health information technology: The Health IT Safety Framework.BMJ Qual Saf. 2016 Apr;25(4):226-32. doi: 10.1136/bmjqs-2015-004486. Epub 2015 Sep 14. BMJ Qual Saf. 2016. PMID: 26369894 Free PMC article. Review.
Cited by
-
Machine Learning for Risk Prediction of Oesophago-Gastric Cancer in Primary Care: Comparison with Existing Risk-Assessment Tools.Cancers (Basel). 2022 Oct 14;14(20):5023. doi: 10.3390/cancers14205023. Cancers (Basel). 2022. PMID: 36291807 Free PMC article.
-
The implementation challenge of computerised clinical decision support systems for the detection of disease in primary care: systematic review and recommendations.Implement Sci. 2025 Jul 17;20(1):33. doi: 10.1186/s13012-025-01445-4. Implement Sci. 2025. PMID: 40671071 Free PMC article.
-
Data-Driven Personalized Care in Lung Cancer: Scoping Review and Clinical Recommendations on Performance Status and Activity Level of Patients With Lung Cancer Using Wearable Devices.JCO Clin Cancer Inform. 2023 Sep;7:e2300016. doi: 10.1200/CCI.23.00016. JCO Clin Cancer Inform. 2023. PMID: 37922433 Free PMC article.
References
-
- Emery JD Shaw K Williams B, et al. : The role of primary care in early detection and follow-up of cancer. Nat Publ Gr 11:38-48, 2014 - PubMed
-
- US Food and Drug Administration : Software as a Medical Device (SAMD): Clinical Evaluation Guidance for Industry and Food and Drug Administration Staff. FDA Guid, 2017, pp 1-32. https://www.fda.gov/media/100714/download
-
- The European Parliment and The Council of the European Union : Council Directive 93/68/EEC of 22 July 1993. Off J Eur Union 68, 1993
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical